Laboratoires Thea

This study tests a new eye drop called T1695 against an existing treatment (ciclosporin) for children aged 4 to 17 with moderate to severe vernal keratoconjunctivitis (VKC), a serious allergic eye condition. The trial will compare how well each treatment reduces damage to the cor…

This study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A exon 13). The drug is injected into the eye and may help preserve vision. The trial will enroll 81 participants, including children as young as 8…

This study tests whether T10430 eye drops can safely slow or stop the progression of nearsightedness (myopia) in children aged 6 to 12. Myopia often starts in childhood and can lead to serious eye problems later in life. The trial will enroll 200 children to check for side effect…

This study tests an experimental drug called sepofarsen in people with a rare genetic eye disease (LCA10) that causes blindness from a specific CEP290 gene mutation. About 32 participants aged 6 and older will receive the drug in one eye and a placebo in the other to see if it im…

This study is testing a new preservative-free eye drop that combines trehalose, sodium hyaluronate, and NAAGA to see if it improves dry eye symptoms and quality of life over 6 months. Thirty adults with dry eye disease will use the drops daily and report their symptoms. The goal …

This study looks at whether a new preservative-free eyelid cream helps people feel more comfortable after eyelid surgery. About 30 adults who are planning eyelid surgery will use the cream twice a day for 3 months. Researchers will measure how satisfied patients are with their ey…